Tax
Income Tax
Alnylam Pharmaceuticals Income Tax increased by 229.3% to $15.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $15.88M to $15.66M. Over 2 years (FY 2022 to FY 2024), Income Tax shows a downward trend with a 388.2% CAGR.
Analysis
StatementIncome Statement
SectionTax
First reportedQ1 2014
Last reportedQ1 2026Apr 30, 2026
Metric ID:
income_tax_expenseHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.23M | $278.00K | $985.00K | $2.73M | -$23.00K | $472.00K | $1.74M | $1.82M | $2.99M | $183.00K | $2.35M | $5.72M | $2.91M | -$110.20M | $15.88M | $30.92M | -$12.12M | $15.66M |
| QoQ Change | — | -77.4% | +254.3% | +177.1% | -100.8% | >999% | +268.4% | +4.4% | +64.6% | -93.9% | >999% | +143.7% | -49.2% | <-999% | +114.4% | +94.7% | -139.2% | +229.3% |
| YoY Change | — | — | — | +122.2% | -108.3% | — | +76.5% | -33.5% | >999% | -61.2% | +35.0% | +215.3% | -2.7% | <-999% | +576.4% | +440.4% | -516.8% | -1.4% |
Range-$110.20M – $30.92M
CAGR+82.0%
Avg YoY Growth<-999%
Median YoY Growth+16.8%
Income Tax at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's income tax?
- Alnylam Pharmaceuticals (ALNY) reported income tax of $15.66M in Q1 2026.
- How has Alnylam Pharmaceuticals's income tax changed year-over-year?
- Alnylam Pharmaceuticals's income tax decreased by 1.4% year-over-year, from $15.88M to $15.66M.
- What is the long-term trend for Alnylam Pharmaceuticals's income tax?
- Over 2 years (2022 to 2024), Alnylam Pharmaceuticals's income tax has grown at a 388.2% compound annual growth rate (CAGR), from $4.16M to -$99.22M.